U.S. Hikes Purchases of COVID-19 Vaccine, Treatment
July 5, 2022
The United States has acquired adult and pediatric doses of the COVID-19 vaccine for delivery in early fall in a contract worth $3.2 billion, as well as an additional 150,000 doses of bebtelovimab for about $275 million.